New experimental approach may help overcome drug resistance in deadly brain cancer

Scientists person identified a promising caller strategy to tackle 1 of the biggest obstacles successful treating glioblastoma, 1 of the astir assertive forms of encephalon cancer: absorption to chemotherapy. The survey shows that an experimental compound called BA-101 tin reconstruct the effectiveness of the modular cause temozolomide (TMZ) by blocking a biologic process known arsenic nitrosative stress, which helps tumors past and defy treatment.